Department Of Health – Abu Dhabi Launch HealthX To Advance Abu Dhabi As Global Biotech, Life Sciences Hub

startAD, an Abu Dhabi-based startup accelerator affiliated with Tamkeen and NYU Abu Dhabi (NYUAD), has partnered with the Department of Health – Abu Dhabi (DoH) to launch HealthX. This startup programme aims to position Abu Dhabi as a leading centre in the biotech and life science industry. Over the next two years, HealthX will integrate 30 global life science startups into the UAE’s healthcare ecosystem.

The agreement was signed by Dr. Asma Ibrahim Al Mannaei, Executive Director of Research and Innovation Centre at DoH, and Ramesh Jagannathan, Managing Director of startAD. The announcement was made during the Abu Dhabi Global Healthcare Week (ADGHW), highlighting both parties' commitment to enhancing the UAE’s innovation credentials in healthcare.

Applications are now open for the first cohort focusing on generative AI in healthcare and life sciences. Future cohorts will cover genomics, precision medicine, neurodegenerative diseases, advanced therapeutics, drug discovery, mental health, and assistive technology for People of Determination.

The incubator offers six weeks of intensive training, personalised support, and potential customer acquisition in the UAE. Participants will develop customised pilot proposals and gain a deep understanding of the UAE market. Successful applicants will access the DoH regulatory sandbox and UAE de-identified data to refine their products.

Support and Networking Opportunities

Participants will benefit from access to labs and collaboration opportunities at leading academic institutes. The business support clinic includes finance, legal, licensing, IP support, ongoing mentorship, and introductions to venture capitalists. Networking prospects include pilot discussions with healthcare partners and licensing opportunities from DoH.

The interconnected ecosystem features key players such as DoH, NMC Healthcare, Burjeel Holdings, and Harley Street Medical Centre. Additionally, participants will join the startAD alumni programme.

Statements from Key Figures

Dr. Asma Ibrahim Al Mannaei stated: "As the regulator of the healthcare sector in the emirate, DoH continues to spearhead borderless collaborations, research and innovation to enable a healthier future for all." She emphasised that this partnership aims to tackle global healthcare challenges through supporting start-ups and enabling innovation.

Ramesh Jagannathan commented: "The future of health holds immense possibilities, and Abu Dhabi aims to be a global leader in the field." He highlighted that their focus is on attracting innovators dedicated to propelling the UAE to the forefront of healthcare research and innovation.

Eligibility Criteria for Startups

The initiative is open to global and local pre-seed to series B startups developing innovative technologies with a clear use case for the Abu Dhabi healthcare industry. A strong team should include at least two members with relevant experience and demonstrated traction through existing pilots and customers.

Startups with a product or minimum viable product (MVP) ready for testing and implementation with corporate customers are encouraged to apply. A clear roadmap showcasing scalability potential is also essential.

Potential Impact on Healthcare

Life sciences and biotechnology are rapidly evolving fields that hold promise in addressing pressing health challenges. These technologies can develop health products and therapies at lower costs than traditional solutions. The Abu Dhabi healthcare market is well-positioned for advanced technology startups to make a tangible impact.

The programme aims to provide a strong platform for startups to address critical challenges in healthcare delivery. It seeks to improve patient outcomes and streamline operations across the healthcare value chain.

With inputs from WAM